Global Bioanalytical Testing Services Market

Report Code: BIO247A

Publish Date: Oct 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.

Report Includes

  • 45 data tables and 44 additional tables
  • An overview of the global market for bioanalytical testing services
  • An estimate of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
  • Characterization and quantification of the global market for bioanalytical testing services on the basis of technology, application, end user and region
  • Information on sample requirements for discovery bioanalysis, preclinical and clinical bioanalysis and descriptions of toxicokinetic and pharmacokinetics studies
  • Coverage of technological advances in the drug discovery process and information on investments in the R&D of biologics, biosimilars and other specialty drugs
  • An examination of the drivers and constraints that will shape the market, and a discussion of the upcoming market opportunities in order to forecast the market by its segments and sub-segments
  • An assessment of existing products as well as those in the pipelines of the major players in the market
  • Coverage of recent advances, emerging technologies and ongoing developments in the industry
  • An evaluation of key industry acquisitions and strategic alliances, and an analysis of the market shares of the leading companies
  • Company profiles of major players within the industry, including SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec

Report Scope

The report’s scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.

The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players’ profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies’ mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.

The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $2.9 billion
Market size forecast $6.6 billion
Growth rate CAGR of 15.2% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Service Type, Application, End User
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, France, Germany, UK, Italy, Spain, Rest of Europe, China, India, Japan, Rest of APAC, Middle East, Africa, South America
Key Market Drivers
  • Rising Incidence of Cancer & Infectious Diseases
  • Rising Trend of Outsourcing Bioanalytical Testing Services
  • Growing Pharmaceutical Research and Development Spending
  • Booming Biopharmaceuticals and Advanced Therapy Medicinal Products Market
Companies studied
AFFIGENIX BIOSOLUTIONS PVT LTD.ALMAC GROUP
ARAGEN LIFE SCIENCES LTD.BIOANALYTICAL SYSTEMS INC.
BIONEEDS INDIA PRIVATE LTD.CHARLES RIVER LABORATORIES INTERNATIONAL INC.
EUROFINS SCIENTIFICINOTIV INC. (ENVIGO)
INTERTEK GROUP PLCLABORATORY CORPORATION OF AMERICA HOLDINGS
PACE ANALYTICALPACIFIC BIOLABS
SARTORIUS AGSGS SA
SYNEOS HEALTHWUXI APPTEC
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The market is projected to grow from $3.2 billion in 2023 to $6.6 billion in 2028 at a compound annual growth rate (CAGR) of 15.2% during the forecast period.
The key factors driving the growth of the bioanalytical testing services market include the rising trend of outsourcing these services coupled with advancements in bioanalytical techniques resulting in high efficiency and better results.
The bioanalytical testing services market is segmented based on service type, application type, end user, and region.
By Service type, cell-based assays followed by bioequivalence & bioavailability studies segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the global bioanalytical testing market.
Key companies in the market include SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec among others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Bioanalytical Testing Services Market167Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview6Free
Chapter- 4: Market Dynamics14Free
Chapter- 5: Global Bioanalytical Testing Services Market by Service Type16Free
Chapter- 6: Global Bioanalytical Testing Services Market by Application12Free
Chapter- 7: Global Bioanalytical Testing Services Market by End User8Free
Chapter- 8: Global Bioanalytical Testing Services Market by Region22Free
Chapter- 9: ESG Developments11Free
Chapter- 10: Emerging Technologies and Developments3Free
Chapter- 11: M&A Analysis2Free
Chapter- 12: Competitive Intelligence6Free
Chapter- 13: Company Profiles56Free

Related Reports

Oncology Biomarkers: Global Markets

Published - Jul 2023 | Publisher - BCC Publishing | Code - BIO244A

The global oncology biomarkers market reached $15.5 billion in 2022, should reach $17.6 billion by 2023 and $35.2 billion by 2028 with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2023-2028.

Biologics Development and Manufacturing Testing: Technologies and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - BIO155B

The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.

Global Oncology Pharmaceuticals Market

Published - Oct 2021 | Publisher - BCC Publishing | Code - PHM256A

The global market for oncology pharmaceuticals should grow from $177.4 billion in 2021 to $313.7 billion by 2026, at compound annual growth rate (CAGR) of 12.1% for the period of 2021-2026.

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Published - Sep 2021 | Publisher - BCC Publishing | Code - PHM043H

The global market for contract pharmaceutical manufacturing, research and packaging services should grow from $168.0 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Bioanalytical Testing Services Market
Sample Report